Opexa Therapeutics (OPXA) CEO Invited to Join Personalized Medicine Panel at New York CEO Conference
11/8/2013 8:07:12 AM
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tcelna®, a patient-specific T-cell immunotherapy for the treatment of multiple sclerosis (MS), today announced that Neil K. Warma, Opexa’s President and Chief Executive Officer, has been invited as a panel member to participate in the New York CEO Conference. The event will take place November 12 - 13, 2013, at the Apella in New York.
Help employers find you! Check out all the jobs and post your resume.
comments powered by